Expressing Human Papilloma Virus Type 16-e7 Tumor Antigen Uses, Dosage, Side Effects and more
Expressing Human Papilloma Virus Type 16-e7 Tumor Antigen Uses, Dosage, Side Effects, Food Interaction and all others data.
Expressing Human Papilloma Virus Type 16-e7 Tumor Antigen is under investigation in clinical trial NCT02853604 (Study of ADXS11-001 in Subjects With High Risk Locally Advanced Cervical Cancer).
Trade Name | Expressing Human Papilloma Virus Type 16-e7 Tumor Antigen |
Generic | Axalimogene filolisbac |
Axalimogene filolisbac Other Names | Adxs hpv, Live, attenuated listeria monocytogenes bacteria, expressing human papilloma virus type 16-e7 tumor antigen, Raligize |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |